The recent years have seen remarkable advancements in cancer research and this has given new hope to patients throughout the world. From innovative therapies to cutting-edge technology, scientists are ...

As of September 30, 2024, the Company maintains a strong cash balance of $11.3 million and an overall working capital balance of $11.3 million. Long term debt as of September 30, 2024 amounted to $3.7 ...

At a news conference last month, Gov. Jared Polis explained why the American health care system is outrageously expensive and ...

Merus’ zenocutuzumab is nearing FDA approval, and petosemtamab shows promise. Learn why MRUS stock could rise as the company ...

SEO and Google Ads serve different but complementary purposes. SEO involves earning high visibility on organic search engine results pages for free through relevant and high-quali ...

Unlike mass-produced pharmaceutical drugs, compounded medications are custom-made to meet the unique needs of individual ...

Most students participate in a scholarly community outreach project or scientific research projects during the summer between ...

Investment in artificial intelligence (AI) is rising fast. The International Data Corporation projects global spending on AI R&D will reach ...

Despite polling consistently showing that voters are deeply concerned about medical care and its costs, neither Donald Trump ...

PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third ...

Brain disorders like Parkinson's (PD) or Alzheimer's Disease (AD) start to develop in patients much earlier than when their first clinical symptoms appear. Treating patients at these early stages ...

Alisha Jucevic for The New ... free. And private insurance companies are not required to cover Jynneos for free until Jan. 1 ...